TY - JOUR
T1 - Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury
AU - Nishimura, Soraya
AU - Yasuda, Akimasa
AU - Iwai, Hiroki
AU - Takano, Morito
AU - Kobayashi, Yoshiomi
AU - Nori, Satoshi
AU - Tsuji, Osahiko
AU - Fujiyoshi, Kanehiro
AU - Ebise, Hayao
AU - Toyama, Yoshiaki
AU - Okano, Hideyuki
AU - Nakamura, Masaya
N1 - Funding Information:
We appreciate the help of Dr. A. Iwanami, Dr. Y. Takahashi, Dr. M. Shinozaki, Dr. T. Konomi, Dr. R. Zhang, Dr. G. Itakura, Dr. S. Tashiro, Dr. S. Kawabata, Dr. Y. Nishiyama, and Dr. K. Hori, members of the spinal cord research team at the Department of Orthopaedic Surgery, Rehabilitation Medicine and Physiology, Keio University School of Medicine. We also thank Ms. T. Harada, Ms. S. Miyao, Ms. M. Mizutani, and Ms. H. Shimada for their assistance with the experiments and animal care. This work was supported by grants from the Japan Science and Technology–California Institute for Regenerative Medicine collaborative program; Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (SPS) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Project for Realization of Regenerative Medicine; Support for Core Institutes for iPS Cell Research from the MEXT; Keio Gijuku Academic Development Funds; by a Grant-in-Aid for the Global COE program from MEXT to Keio University; and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the MEXT.
PY - 2013
Y1 - 2013
N2 - Background: The transplantation of neural stem/progenitor cells (NS/PCs) at the sub-acute phase of spinal cord injury, but not at the chronic phase, can promote functional recovery. However, the reasons for this difference and whether it involves the survival and/or fate of grafted cells under these two conditions remain unclear. To address this question, NS/PC transplantation was performed after contusive spinal cord injury in adult mice at the sub-acute and chronic phases. Results: Quantitative analyses using bio-imaging, which can noninvasively detect surviving grafted cells in living animals, revealed no significant difference in the survival rate of grafted cells between the sub-acute and chronic transplantation groups. Additionally, immunohistology revealed no significant difference in the differentiation phenotypes of grafted cells between the two groups. Microarray analysis revealed no significant differences in the expression of genes encoding inflammatory cytokines or growth factors, which affect the survival and/or fate of grafted cells, in the injured spinal cord between the sub-acute and chronic phases. By contrast, the distribution of chronically grafted NS/PCs was restricted compared to NS/PCs grafted at the sub-acute phase because a more prominent glial scar located around the lesion epicenter enclosed the grafted cells. Furthermore, microarray and histological analysis revealed that the infiltration of macrophages, especially M2 macrophages, which have anti-inflammatory role, was significantly higher at the sub-acute phase than the chronic phase. Ultimately, NS/PCs that were transplanted in the sub-acute phase, but not the chronic phase, promoted functional recovery compared with the vehicle control group. Conclusions: The extent of glial scar formation and the characteristics of inflammation is the most remarkable difference in the injured spinal cord microenvironment between the sub-acute and chronic phases. To achieve functional recovery by NS/PC transplantation in cases at the chronic phase, modification of the microenvironment of the injured spinal cord focusing on glial scar formation and inflammatory phenotype should be considered.
AB - Background: The transplantation of neural stem/progenitor cells (NS/PCs) at the sub-acute phase of spinal cord injury, but not at the chronic phase, can promote functional recovery. However, the reasons for this difference and whether it involves the survival and/or fate of grafted cells under these two conditions remain unclear. To address this question, NS/PC transplantation was performed after contusive spinal cord injury in adult mice at the sub-acute and chronic phases. Results: Quantitative analyses using bio-imaging, which can noninvasively detect surviving grafted cells in living animals, revealed no significant difference in the survival rate of grafted cells between the sub-acute and chronic transplantation groups. Additionally, immunohistology revealed no significant difference in the differentiation phenotypes of grafted cells between the two groups. Microarray analysis revealed no significant differences in the expression of genes encoding inflammatory cytokines or growth factors, which affect the survival and/or fate of grafted cells, in the injured spinal cord between the sub-acute and chronic phases. By contrast, the distribution of chronically grafted NS/PCs was restricted compared to NS/PCs grafted at the sub-acute phase because a more prominent glial scar located around the lesion epicenter enclosed the grafted cells. Furthermore, microarray and histological analysis revealed that the infiltration of macrophages, especially M2 macrophages, which have anti-inflammatory role, was significantly higher at the sub-acute phase than the chronic phase. Ultimately, NS/PCs that were transplanted in the sub-acute phase, but not the chronic phase, promoted functional recovery compared with the vehicle control group. Conclusions: The extent of glial scar formation and the characteristics of inflammation is the most remarkable difference in the injured spinal cord microenvironment between the sub-acute and chronic phases. To achieve functional recovery by NS/PC transplantation in cases at the chronic phase, modification of the microenvironment of the injured spinal cord focusing on glial scar formation and inflammatory phenotype should be considered.
KW - Cell transplantation
KW - Chronic phase
KW - Microenvironment
KW - Neural stem/progenitor cells
KW - Spinal cord injury
UR - http://www.scopus.com/inward/record.url?scp=84871962001&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871962001&partnerID=8YFLogxK
U2 - 10.1186/1756-6606-6-3
DO - 10.1186/1756-6606-6-3
M3 - Article
C2 - 23298657
AN - SCOPUS:84871962001
SN - 1756-6606
VL - 6
JO - Molecular Brain
JF - Molecular Brain
IS - 1
M1 - 3
ER -